COAX 发表于 2025-3-21 18:17:22

        SCIE(SCI)期刊INFLAMMOPHARMACOLOGY(20 21 REV HIST)影响因子<br>        http://figure.impactfactor.cn/if/?ISSN=0925-4692<br><br>        SCIE(SCI)期刊INFLAMMOPHARMACOLOGY(INFLAMMOPHARMACOLOGY)影响因子@(免疫学)学科排名<br>        http://figure.impactfactor.cn/ifr/?ISSN=0925B4692<br><br>        SCIE(SCI)期刊INFLAMMOPHARMACOLOGY(20 21 REV HIST)总引论文<br>        http://figure.impactfactor.cn/at/?ISSN=0925-4692<br><br>        SCIE(SCI)期刊INFLAMMOPHARMACOLOGY(INFLAMMOPHARMACOLOGY)总引论文@(免疫学)学科排名<br>        http://figure.impactfactor.cn/atr/?ISSN=0925B4692<br><br>        SCIE(SCI)期刊INFLAMMOPHARMACOLOGY(20 21 REV HIST)影响因子<br>        http://figure.impactfactor.cn/tc/?ISSN=0925-4692<br><br>        SCIE(SCI)期刊INFLAMMOPHARMACOLOGY(INFLAMMOPHARMACOLOGY)总引频次@(免疫学)学科排名<br>        http://figure.impactfactor.cn/tcr/?ISSN=0925B4692<br><br>        SCIE(SCI)期刊INFLAMMOPHARMACOLOGY(20 21 REV HIST)即时影响因子<br>        http://figure.impactfactor.cn/ii/?ISSN=0925-4692<br><br>        SCIE(SCI)期刊INFLAMMOPHARMACOLOGY(INFLAMMOPHARMACOLOGY)即时影响因子@(免疫学)学科排名<br>        http://figure.impactfactor.cn/iir/?ISSN=0925B4692<br><br>        SCIE(SCI)期刊INFLAMMOPHARMACOLOGY(20 21 REV HIST)五年累积影响因子<br>        http://figure.impactfactor.cn/5y/?ISSN=0925-4692<br><br>        SCIE(SCI)期刊INFLAMMOPHARMACOLOGY(INFLAMMOPHARMACOLOGY)五年累积影响因子@(免疫学)学科排名<br>        http://figure.impactfactor.cn/5yr/?ISSN=0925B4692<br><br>       

范例 发表于 2025-3-21 20:19:40

Submitted on: 29 January 2014.
Revised on: 14 March 2014.
Accepted on: 10 May 2014.

___________________INFLAMMOPHARMACOLOGY---SPRINGER BASEL AG

Obvious 发表于 2025-3-22 01:33:37

Submitted on: 21 January 2010.
Revised on: 18 February 2010.
Accepted on: 18 March 2010.

___________________INFLAMMOPHARMACOLOGY---SPRINGER BASEL AG

intercede 发表于 2025-3-22 05:13:28

http://reply.papertrans.cn/2/126/12523/12523-4.png

存心 发表于 2025-3-22 09:24:45

http://reply.papertrans.cn/2/126/12523/12523-5.png

Visual-Acuity 发表于 2025-3-22 14:12:54

Submitted on: 27 April 2022.
Revised on: 10 June 2022.
Accepted on: 31 July 2022.

___________________INFLAMMOPHARMACOLOGY---SPRINGER BASEL AG

Ebct207 发表于 2025-3-22 17:48:17

Submitted on: 01 April 2022.
Revised on: 18 May 2022.
Accepted on: 16 July 2022.

___________________INFLAMMOPHARMACOLOGY---SPRINGER BASEL AG

abracadabra 发表于 2025-3-22 23:53:29

http://reply.papertrans.cn/2/126/12523/12523-8.png

chlorosis 发表于 2025-3-23 04:43:45

http://reply.papertrans.cn/2/126/12523/12523-9.png

oblique 发表于 2025-3-23 09:28:08

Submitted on: 18 October 2002.
Revised on: 19 December 2002.
Accepted on: 18 January 2003.

___________________INFLAMMOPHARMACOLOGY---SPRINGER BASEL AG
页: [1] 2 3 4
查看完整版本: SCIE期刊INFLAMMOPHARMACOLOGY 2024/2025影响因子:4.674 (INFLAMMOPHARMACOLOGY) (0925-4692). (IMMUNOLOGY)(免疫学)Science Citation In